Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Improving Patient Access to Stroke Therapy Study

Trial Profile

Improving Patient Access to Stroke Therapy Study

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 07 Mar 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Alteplase (Primary)
  • Indications Embolism and thrombosis; Stroke; Transient ischaemic attacks
  • Focus Therapeutic Use
  • Acronyms IMPACT

Most Recent Events

  • 01 Mar 2017 Status changed from suspended to discontinued.
  • 06 Nov 2015 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
  • 06 Apr 2015 Planned End Date changed from 1 Jul 2014 to 1 Jun 2017 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top